Previous evidence that constitutive activation of Notch1 and Notch2 signaling contributes to apoptosis resistance in CLL also underscores the importance of Notch in this leukemia [8, 9], encouraging further investigation of its therapeutic potential. Here, NOTCH2 is linked to B-cell chronic lymphocytic leukemia.